RAGE and its ligands: a lasting memory in diabetic complications?

Abstract:

:The complications of diabetes are myriad and represent a rising cause of morbidity and mortality, particularly in the Western world. The update of the Diabetes Control and Clinical Trials Group/Epidemiology of Diabetes Interventions and Complications Research Group (DCCT/EDIC) suggested that previous strict control of hyperglycaemia was associated with reduced carotid atherosclerosis compared to conventional treatment, even after levels of glycosylated haemoglobin between the two treatment groups became indistinguishable. These intriguing findings prompt the key question, why does the blood vessel 'remember'? This review focuses on the hypothesis that the ligand/RAGE axis contributes importantly to glycaemic 'memory'. Studies in rodent models of diabetes suggest that blockade or genetic modification of RAGE suppress diabetes-associated progression of atherosclerosis, exaggerated neointimal expansion consequent to acute arterial injury, and cardiac dysfunction. We propose that therapeutic RAGE blockade will intercept maladaptive diabetes-associated memory in the vessel wall and provide cardiovascular protection in diabetes.

journal_name

Diab Vasc Dis Res

authors

Yan SF,Ramasamy R,Bucciarelli LG,Wendt T,Lee LK,Hudson BI,Stern DM,Lalla E,DU Yan S,Rong LL,Naka Y,Schmidt AM

doi

10.3132/dvdr.2004.001

keywords:

subject

Has Abstract

pub_date

2004-05-01 00:00:00

pages

10-20

issue

1

eissn

1479-1641

issn

1752-8984

journal_volume

1

pub_type

杂志文章,评审
  • Copeptin in patients with acute myocardial infarction and newly detected glucose abnormalities - A marker of increased stress susceptibility? A report from the Glucose in Acute Myocardial Infarction cohort.

    abstract:OBJECTIVE:To characterize copeptin levels and to explore its prognostic importance in patients with acute myocardial infarction with newly detected glucose abnormalities. METHODS:Copeptin was measured in 166 patients with acute myocardial infarction without known diabetes and in 168 age- and gender-matched controls. P...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,多中心研究

    doi:10.1177/1479164116664490

    authors: Smaradottir MI,Ritsinger V,Gyberg V,Norhammar A,Näsman P,Mellbin LG

    更新日期:2017-03-01 00:00:00

  • Association between interarm blood pressure differences and diabetic retinopathy in patients with type 2 diabetes.

    abstract:BACKGROUND:The effect of interarm blood pressure difference on the development of diabetic retinopathy, proteinuria and chronic kidney disease remains unknown. We investigated to determine the impact of interarm blood pressure difference on the prevalence of diabetic retinopathy, proteinuria and chronic kidney disease ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164120945910

    authors: Lee JH,Kim YA,Lee Y,Bang WD,Seo JH

    更新日期:2020-07-01 00:00:00

  • Atherosclerosis in type 2 diabetes: a role for fibrate therapy?

    abstract::Vascular complications associated with type 2 diabetes confer significant morbidity and mortality. Atherosclerosis develops much earlier and progresses more rapidly than in subjects without diabetes. The clustering of cardiovascular risk factors associated with type 2 diabetes is mainly responsible for accelerated ath...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.3132/dvdr.2007.067

    authors: Steiner G

    更新日期:2007-12-01 00:00:00

  • Metabolic syndrome, aging, physical inactivity, and incidence of type 2 diabetes in general African population.

    abstract::The first objective of this study was to determine the baseline prevalence of metabolic syndrome and its individual components using the NCEP-R/ATPIII criteria, IDF criteria for Europe, and IDF criteria for Africa: waist circumference of at least 94 cm for men and women. The second objective was to investigate the inc...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164109346362

    authors: Longo-Mbenza B,On'kin JB,Okwe AN,Kabangu NK,Fuele SM

    更新日期:2010-01-01 00:00:00

  • Effects of sodium glucose co-transporter 2 inhibitors on the kidney.

    abstract::Sodium-glucose cotransporter 2 inhibitors are antihyperglycaemic medications with an emerging evidence base for cardiovascular and kidney disease risk reduction. Sodium-glucose cotransporter 2 inhibitors medications lower plasma glucose by inhibiting glucose reabsorption in the proximal tubule of the kidney independen...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.1177/1479164118783756

    authors: de Albuquerque Rocha N,Neeland IJ,McCullough PA,Toto RD,McGuire DK

    更新日期:2018-09-01 00:00:00

  • The importance of low serum levels of high-density lipoprotein cholesterol (HDL-C) as a cardiovascular risk factor.

    abstract::In order to discuss and establish a joint position on the treatment of low serum levels of high-density lipoprotein cholesterol (HDL-C), a group of experts involved in the care of people with dyslipidaemia and at risk of cardiovascular disease met in Miami, Florida, U.S., on 5th and 6th March 2005. The experts came fr...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,实务指引

    doi:10.3132/dvdr.2005.016

    authors: Espinosa-Larrañaga F,Vejar-Jalaf M,Medina-Santillán R,Latin American Group.

    更新日期:2005-10-01 00:00:00

  • Interrelationship of canonical and non-canonical Wnt signalling pathways in chronic metabolic diseases.

    abstract::Chronic diseases account for approximately 45% of all deaths in developed countries and are particularly prevalent in countries with the most sophisticated and robust public health systems. Chronic metabolic diseases, specifically lifestyle-related diseases pertaining to diet and exercise, continue to be difficult to ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.1177/1479164117738442

    authors: Ackers I,Malgor R

    更新日期:2018-01-01 00:00:00

  • Insulin resistance and insulin hypersecretion in the metabolic syndrome and type 2 diabetes: Time for a conceptual framework shift.

    abstract::While few dispute the existence of the metabolic syndrome as a clustering of factors indicative of poor metabolic health, its utility above that of its individual components in the clinical care of individual patients is questioned. This is likely a consequence of the failure of clinicians and scientists to agree on a...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.1177/1479164119827611

    authors: Nolan CJ,Prentki M

    更新日期:2019-03-01 00:00:00

  • Sub-optimal achievement of guideline-derived lipid goals in management of diabetes patients with atherosclerotic cardiovascular disease, despite high use of evidence-based therapies.

    abstract::Guidelines recommend aggressive goals for lipid and blood pressure reduction for high risk patients with diabetes mellitus and atherosclerotic coronary disease. However, it remains unclear how many patients achieve treatment goals versus the number of people merely placed on treatment. We conducted an observational st...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164111431471

    authors: DeGuzman PB,Akosah KO,Simpson AG,Barbieri KE,Megginson GC,Goldberg RI,Beller GA

    更新日期:2012-04-01 00:00:00

  • Skin microvascular function in patients with type 1 diabetes: An observational study from the onset of diabetes.

    abstract:BACKGROUND:The development of disturbances in skin microcirculation in type 1 diabetes is not well characterised. We assessed skin microcirculation longitudinally from the onset of diabetes up to 29 years of duration to investigate when such disturbances start. MATERIAL AND METHODS:Seventeen adult patients with type 1...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164117694463

    authors: Santesson P,Lins PE,Kalani M,Adamson U,Lelic I,von Wendt G,Fagrell B,Jörneskog G

    更新日期:2017-05-01 00:00:00

  • How sensitive and specific is continuous-wave Doppler for detecting peripheral arterial disease in people with and without diabetes? A cross-sectional study.

    abstract:BACKGROUND:Continuous-wave Doppler is frequently used for detecting peripheral arterial disease in patients with diabetes; however, there is limited evidence investigating diagnostic accuracy. This study aimed to determine sensitivity and specificity of continuous-wave Doppler for detecting peripheral arterial disease ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164118782887

    authors: Tehan PE,Sebastian M,Barwick AL,Chuter VH

    更新日期:2018-09-01 00:00:00

  • Respond to the letter on 'Interobserver reliability of the ankle brachial index, toe-brachial index and distal pulse palpation in patients with diabetes: a methodological issue'.

    abstract::We respond to the letter of Nadery and Shahsavari regarding our paper entitled 'Interobserver reliability of the ankle brachial index, toe -brachial index and distal pulse palpation in patients with diabetes. In this letter, we concluded that despite some limitations, the kappa coefficient is an informative measure of...

    journal_title:Diabetes & vascular disease research

    pub_type: 评论,信件

    doi:10.1177/1479164118794901

    authors: Álvaro Afonso FJ,García-Morales E,Molines-Barroso RJ,García-Álvarez Y,Sanz-Corbalán I,Lázaro-Martínez JL

    更新日期:2018-11-01 00:00:00

  • Detection and characterisation of microcirculatory abnormalities in the skin of diabetic patients with microvascular complications.

    abstract::The aim of this study was to characterise microvascular blood flow in the skin and to compare it with biomarkers of endothelial dysfunction and tissue inflammation in patients with type 2 diabetes with (n=20) or without (n=20) microvascular complications and 20 control subjects. Microvascular function was measured by ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.3132/dvdr.2008.006

    authors: Brooks BA,McLennan SV,Twigg SM,Yue DK

    更新日期:2008-03-01 00:00:00

  • Reduced endothelial activation after exercise is associated with improved HbA1c in patients with type 2 diabetes and coronary artery disease.

    abstract:OBJECTIVE:We have previously reported insignificant changes in HbA1c after exercise in patients with both type 2 diabetes and coronary artery disease. In this study, we investigated the effect of exercise on endothelial function and possible associations between changes in endothelial function and HbA1c. METHODS:Patie...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/1479164116679077

    authors: Byrkjeland R,Njerve IU,Arnesen H,Seljeflot I,Solheim S

    更新日期:2017-03-01 00:00:00

  • Effect of 12-month intervention with low-dose atorvastatin on pulse wave velocity in subjects with type 2 diabetes and dyslipidaemia.

    abstract::Cardiovascular disease is the leading cause of morbidity and mortality in subjects with type 2 diabetes mellitus. Increased aortic stiffness, assessed with the carotid-femoral pulse wave velocity, is an independent risk factor for cardiovascular disease. Statins reduce effectively cardiovascular disease and mortality ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164118805320

    authors: Grigoropoulou P,Tentolouris A,Eleftheriadou I,Tsilingiris D,Vlachopoulos C,Sykara M,Tentolouris N

    更新日期:2019-01-01 00:00:00

  • Ablation of angiotensin type 2 receptor prevents endothelial nitric oxide synthase glutathionylation and nitration in ischaemic abductor muscle of diabetic mice.

    abstract::Peripheral artery disease is a severe complication of diabetes. We have reported that the deletion of angiotensin type 2 receptor in diabetic mice promoted vascular angiogenesis in the ischaemic muscle 4 weeks following ischaemia. However, the angiotensin type 2 receptor deletion beneficial effects occurred 2 weeks po...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164119883978

    authors: Robillard S,Mercier C,Breton V,Paquin-Veillette J,Guay A,Lizotte F,Geraldes P

    更新日期:2020-01-01 00:00:00

  • Treating insulin resistance: future prospects.

    abstract::Insulin resistance typically reflects multiple defects of insulin receptor and post-receptor signalling that impair a diverse range of metabolic and vascular actions. Many potential intervention targets and compounds with therapeutic activity have been described. Proof of principle for a non-peptide insulin mimetic ha...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.3132/dvdr.2007.002

    authors: Bailey CJ

    更新日期:2007-03-01 00:00:00

  • Pancreatic-β-cell survival and proliferation are promoted by protein kinase G type Iα and downstream regulation of AKT/FOXO1.

    abstract::Early studies showed nitric oxide as a pro-inflammatory-cytokine-induced toxin involved in pancreatic β-cell destruction during pathogenesis of type-1 diabetes. However, nitric oxide has both cytotoxic and cytoprotective effects on mammalian cells, depending on concentration and micro-environmental surroundings. Our s...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164117713947

    authors: Wong JC,Vo V,Gorjala P,Fiscus RR

    更新日期:2017-09-01 00:00:00

  • Early stage detection of conduit artery endothelial dysfunction in patients with type 1 diabetes.

    abstract::Flow-mediated dilatation evaluation using hand skin heating may possibly be more accurate than post-ischaemic hyperaemia to detect conduit artery endothelial dysfunction in type 1 diabetes. We measured in 24 type 1 diabetic patients (n=16 without microangiopathy) and 24 healthy matched subjects radial artery diameter ...

    journal_title:Diabetes & vascular disease research

    pub_type: 临床试验,杂志文章

    doi:10.1177/1479164109360470

    authors: Bellien J,Costentin A,Dutheil-Maillochaud B,Iacob M,Kuhn JM,Thuillez C,Joannides R

    更新日期:2010-04-01 00:00:00

  • Rapid effect of single-dose rosiglitazone treatment on endothelial function in healthy men with normal glucose tolerance: data from a randomised, placebo-controlled, double-blind study.

    abstract::Antidiabetic thiazolidinediones (TZDs) improve endothelial function in patients with or without type 2 diabetes. The present randomised, placebo-controlled, double-blind study examined the time course of a single dose of rosiglitazone on flow-mediated endothelium-dependent vasodilation (FMD), metabolic parameters, and...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/1479164110367812

    authors: Walcher T,Walcher D,Hetzel J,Mielke C,Rau M,Rittig K,Balletshofer B,Schwedhelm E,Hombach V,Böger RH,Koenig W,Marx N

    更新日期:2010-07-01 00:00:00

  • Anti-inflammatory effects of simvastatin on adipokines in type 2 diabetic patients with carotid atherosclerosis.

    abstract:OBJECTIVE:Statins are extensively used for lowering LDL-cholesterol and reducing cardiovascular events. Recent studies have shown that statins have beneficial anti-inflammatory effects. We aimed to determine whether and how adipokines are regulated during statin treatment in type 2 diabetic patients. METHOD:In this st...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/1479164109339966

    authors: Hu Y,Tong G,Xu W,Pan J,Ryan K,Yang R,Shuldiner AR,Gong DW,Zhu D

    更新日期:2009-10-01 00:00:00

  • Prevalence of metabolic syndrome in young patients with acute MI: does the Framingham Risk Score underestimate cardiovascular risk in this population?

    abstract::To assess the prevalence of metabolic syndrome (MS) and estimates of global risk by Framingham Risk Score in young subjects with acute myocardial infarction (MI), we assessed metabolic parameters and global risk assessment in 165 consecutive subjects who presented with myocardial infarction prior to 45 years of age. N...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.3132/dvdr.2006.012

    authors: Zarich S,Luciano C,Hulford J,Abdullah A

    更新日期:2006-09-01 00:00:00

  • The effects of telmisartan treatment on the abdominal fat depot in patients with metabolic syndrome and essential hypertension: Abdominal fat Depot Intervention Program of Okayama (ADIPO).

    abstract::Telmisartan partially activates the peroxisome proliferator-activated receptor γ (PPARγ), which may ameliorate the accumulation of visceral adipose tissues and sensitise insulin action. Nineteen patients with essential hypertension and metabolic syndrome were randomly assigned to receive 40 mg of telmisartan (TELMI gr...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/1479164112444640

    authors: Murakami K,Wada J,Ogawa D,Horiguchi CS,Miyoshi T,Sasaki M,Uchida HA,Nakamura Y,Makino H

    更新日期:2013-01-01 00:00:00

  • The combination of OLmesartan and a CAlcium channel blocker (azelnidipine) or candesartan and a calcium channel blocker (amlodipine) in type 2 diabetic hypertensive patients: the OLCA study.

    abstract::Angiotensin II receptor blockers (ARB) are often co-administered with a calcium channel blocker (CCB) for treating hypertension. In this open-label randomised study, untreated diabetic hypertensive patients were randomised to receive either olmesartan 20 mg/day or candesartan 8 mg/day for 12 weeks. Patients with blood...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/1479164112447310

    authors: Daikuhara H,Kikuchi F,Ishida T

    更新日期:2012-10-01 00:00:00

  • Volumes of coronary plaque disease in relation to body mass index, waist circumference, truncal fat mass and epicardial adipose tissue in patients with type 2 diabetes mellitus and controls.

    abstract:OBJECTIVES:Coronary atherosclerosis in patients with type 2 diabetes mellitus may be promoted by regional fat distribution. We investigated the association between anthropometric measures of obesity, truncal fat mass, epicardial adipose tissue and coronary atherosclerosis in asymptomatic patients and matched controls. ...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164119825761

    authors: Gullaksen S,Funck KL,Laugesen E,Hansen TK,Dey D,Poulsen PL

    更新日期:2019-07-01 00:00:00

  • Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.

    abstract:OBJECTIVES:Assess the effect of risk factors changes on risk for cardiovascular disease and mortality in patients with type 2 diabetes selected from the Swedish National Diabetes Register. METHODS:Observational study of 13,477 females and males aged 30-75 years, with baseline HbA1c 41-67 mmol/mol, systolic blood press...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164116637311

    authors: Eeg-Olofsson K,Zethelius B,Gudbjörnsdottir S,Eliasson B,Svensson AM,Cederholm J

    更新日期:2016-07-01 00:00:00

  • Variability of clopidogrel response in patients with type 2 diabetes mellitus.

    abstract::The global prevalence of diabetes mellitus (DM) continues to climb, and is accompanied by an increase in DM associated complications, most often manifesting as coronary heart disease. Platelet dysfunction has been implicated as a central contributor to the increased risk of coronary artery disease in patients with DM,...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.1177/1479164111420890

    authors: Hall HM,Banerjee S,McGuire DK

    更新日期:2011-10-01 00:00:00

  • Insulin resistance: Impact on therapeutic developments in diabetes.

    abstract::Insulin resistance has a broad pathogenic impact affecting metabolic, cardio-renal and other disease areas. Extensive studies to dissect the mechanisms of insulin resistance have provided valuable insights to shape current clinical awareness and advance therapeutic practice. However, the development of direct interven...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,评审

    doi:10.1177/1479164119827570

    authors: Bailey CJ

    更新日期:2019-03-01 00:00:00

  • Increased circulating levels of musclin in newly diagnosed type 2 diabetic patients.

    abstract:BACKGROUND:Musclin is a newly identified skeletal muscle-derived secretory factor, which has been recently characterized as a stimulator that induces insulin resistance in mice. However, the pathophysiological role of musclin in humans remains poorly understood. The aim of this study was to explore the potential correl...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章

    doi:10.1177/1479164116675493

    authors: Chen WJ,Liu Y,Sui YB,Zhang B,Zhang XH,Yin XH

    更新日期:2017-03-01 00:00:00

  • Association of sulphonylurea treatment with all-cause and cardiovascular mortality: a systematic review and meta-analysis of observational studies.

    abstract::We conducted a meta-analysis of cohort and case-control studies to evaluate all-cause and cardiovascular (CV) mortality of patients with type 2 diabetes mellitus (T2DM) who received sulphonylurea (SU) treatment, when compared to any other diabetes treatment. Only studies reporting raw data on mortality during SU treat...

    journal_title:Diabetes & vascular disease research

    pub_type: 杂志文章,meta分析,评审

    doi:10.1177/1479164112465442

    authors: Forst T,Hanefeld M,Jacob S,Moeser G,Schwenk G,Pfützner A,Haupt A

    更新日期:2013-07-01 00:00:00